Education
About Us
Working with TipRanks
Follow Us
Microbix Biosystms (TSE:MBX)
:MBX
MBX Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.29 - C$0.55
Previous CloseN/A
Volume37.35K
Average Volume (3M)126.99K
Market Cap
C$49.36M
Enterprise ValueC$39.16M
Total Cash (Recent Filing)C$12.87M
Total Debt (Recent Filing)C$6.72M
Price to Earnings (P/E)25.0
Beta-0.16
Next Earnings
May 14, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding141,031,740
10 Day Avg. Volume87,902
30 Day Avg. Volume126,992
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.45
Price to Cash Flow (P/CF)17.80
P/FCF Ratio23.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$1.11Price Target Upside208.33% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Microbix Biosystms News
PremiumCompany Announcements
Microbix to Showcase Diagnostic Innovations at ESCMID Global 2025
PremiumCompany Announcements
Microbix Biosystems Navigates Tariff Challenges with Strategic Growth
PremiumCompany Announcements
Microbix Biosystems Announces Successful Shareholder Meeting Outcomes
PremiumCompany Announcements
Microbix Optimizes Capital Structure for Greater Financial Flexibility
PremiumCompany Announcements
Microbix Partners with ACPCC to Combat Cervical Cancer in Indo-Pacific
PremiumCompany Announcements
Microbix Hosts Ontario Premier, Showcases Innovations in Life Sciences
PremiumCompany Announcements
Microbix Biosystems Issues Stock Options to Retain Key Personnel---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceMicrobix reported FY1Q-2025 financials beating Bloom Burton’s estimates.
Trade AgreementMicrobix products are currently exempt from tariffs under the USMCA trade agreement, allowing sales into the U.S. without additional costs.
Bears Say
Market DemandThe unusually light burden of respiratory infectious diseases in China has decreased the demand for Microbix's antigen shipments.
Revenue DeclineTotal revenues declined 28% Y/Y.
---
Options Prices
Currently, No data available
---
Ownership Overview
15.26% Insiders
―
Mutual Funds
― Other Institutional Investors
84.74% Public Companies and
Individual Investors
MBX FAQ
What was Microbix Biosystms’s price range in the past 12 months?
Microbix Biosystms lowest stock price was C$0.29 and its highest was C$0.55 in the past 12 months.
What is Microbix Biosystms’s market cap?
Microbix Biosystms’s market cap is C$49.36M.
When is Microbix Biosystms’s upcoming earnings report date?
Microbix Biosystms’s upcoming earnings report date is May 14, 2025 which is in 19 days.
How were Microbix Biosystms’s earnings last quarter?
Microbix Biosystms released its earnings results on Feb 13, 2025. The company reported C$0.006 earnings per share for the quarter, beating the consensus estimate of N/A by C$0.006.
Is Microbix Biosystms overvalued?
According to Wall Street analysts Microbix Biosystms’s price is currently Undervalued.
Does Microbix Biosystms pay dividends?
Microbix Biosystms does not currently pay dividends.
What is Microbix Biosystms’s EPS estimate?
Microbix Biosystms’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Microbix Biosystms have?
Microbix Biosystms has 141,031,740 shares outstanding.
What happened to Microbix Biosystms’s price movement after its last earnings report?
Microbix Biosystms reported an EPS of C$0.006 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Microbix Biosystms?
Currently, no hedge funds are holding shares in TSE:MBX
---
Microbix Biosystms Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$1.11 (208.33% Upside)
C$1.11 (208.33% Upside)
Insider Transactions
Sold Shares
Worth C$569.6K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
5.97%
12-Months-Change
Fundamentals
Return on Equity
6.85%
Trailing 12-Months
Asset Growth
7.06%
Trailing 12-Months
Company Description
Microbix Biosystms
Microbix Biosystems Inc. (MBX) is a biotechnology company headquartered in Canada that specializes in the development and commercialization of biological products and technologies. The company operates in the life sciences sector and focuses on three main areas: the manufacture of viral and bacterial antigens for the diagnostics industry, the development of quality assessment products (QAPs) for infectious disease diagnostics, and the production of biologic solutions for research and development purposes.
---
MBX Stock 12 Month Forecast
Average Price Target
C$1.11
▲(208.33% Upside)
Technical Analysis
Best Analysts Covering MBX
1 Year
1 Year Success Rate
3/7 ratings generated profit
1 Year Average Return
-1.61%
reiterated a buy rating 17 days ago
Copying David Martin PhD's trades and holding each position for 1 Year would result in 42.86% of your transactions generating a profit, with an average return of -1.61% per trade.
---